← Food and Drug Administration

What podcasts say about Food and Drug Administration

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Food and Drug Administration

22 statements · 12 positive · 7 negative · 3 neutral

  1. Chris GarabedianNegativeNov 20, 2026· Biotech Hangout

    FDA leadership uncertainty risks increasing volatility.

    “I certainly think it risks more volatility”

    Listen at 18:36

    Open the episode · Episode 204 - November 20, 2026
  2. Matt GlineNegativeNov 20, 2026· Biotech Hangout

    Regulatory uncertainty harms biotech companies.

    “Uncertainty is harmful.”

    Listen at 21:35

    Open the episode · Episode 204 - November 20, 2026
  3. Matt GlinePositiveNov 20, 2026· Biotech Hangout

    The FDA has largely maintained professional, consistent, technocratic operations.

    “mostly drugs are getting approved. Our interactions with FDA have been professional. They've been thoughtful. They've been consistent. They've been technocratic”

    Listen at 21:53

    Open the episode · Episode 204 - November 20, 2026
  4. Brian SkorneyPositiveNov 20, 2026· Biotech Hangout
    “I think it will be close to a record year of drug approvals”

    Listen at 22:53

    Open the episode · Episode 204 - November 20, 2026
  5. Paul MatteisNeutralNov 13, 2026· Biotech Hangout

    The FDA’s biggest need is additional staffing.

    “the biggest need at the FDA is just like getting more people”

    Listen at 14:44

    Open the episode · Episode 203 - November 13, 2026
  6. Steve UsdinNegativeNov 10, 2026· BioCentury This Week

    FDA likely will lack a confirmed permanent commissioner for the rest of Trump’s administration.

    “The most likely outcome is there will not be a confirmed permanent commissioner, I think, for the rest of the Trump administration.”

    Listen at 6:44

    Open the episode · Ep. 397 - What the U.S. midterms mean for biopharma
  7. Paul MatteisPositiveNov 6, 2026· Biotech Hangout

    The FDA should restore credibility, standards, and consistency.

    “I want the FDA to get back to a point, right, where we kind of like... look up to the FDA and the standard and the consistency.”

    Listen at 6:40

    Open the episode · Episode 202 - November 6, 2026
  8. The FDA has lacked knowledge of food ingredients and their quantities.

    “the FDA, up until we just closed it, did not know what's in our food, doesn't know.”

    Listen at 1:59:36

    Open the episode · #2578 - Calley Means
  9. D.A. WallachPositiveNov 6, 2026· TBPN

    The FDA plays an important global role because it is trusted on drug safety.

    “The United States FDA plays a really important function globally because everyone trusts us. to be hard asses about drug safety.”

    Listen at 2:09:58

    Open the episode · AI Boom Reality Check, Jobs Boom, Cybertruck Scrapped | Praveer Melwani, Keller Cliffton, Rahul Sonwalkar, Max Siegelman, D.A. Wallach
  10. D.A. WallachPositiveNov 6, 2026· TBPN

    The FDA effectively protects patients and supports trust in medicines.

    “the FDA, I think does a really nice job. keeping patients safe, making sure we trust the medicines we're getting.”

    Listen at 2:10:28

    Open the episode · AI Boom Reality Check, Jobs Boom, Cybertruck Scrapped | Praveer Melwani, Keller Cliffton, Rahul Sonwalkar, Max Siegelman, D.A. Wallach
  11. D.A. WallachNeutralNov 6, 2026· TBPN

    FDA drug approval requires evidence of both safety and effectiveness.

    “for the FDA to approve a drug, they've got to believe that the company has proven it is both safe. And effective.”

    Listen at 2:10:51

    Open the episode · AI Boom Reality Check, Jobs Boom, Cybertruck Scrapped | Praveer Melwani, Keller Cliffton, Rahul Sonwalkar, Max Siegelman, D.A. Wallach
  12. Joe RoganNegativeOct 29, 2026· The Joe Rogan Experience

    Insufficient FDA diligence can allow harmful drugs onto the market before withdrawal.

    “they would look into all the adverse drug deaths and all the different people that die because of these fucking drugs that... wind up getting pulled from the market because the FDA didn't do their due diligence when they passed them.”

    Listen at 1:19:46

    Open the episode · #2572 - Colum Tyrrell
  13. Jordi HaysNegativeOct 19, 2026· TBPN

    FDA approval for medical devices can take a decade.

    “It takes a decade for the FDA to actually approve it.”

    Listen at 4:43

    Open the episode · "You Can See Everything" Sparks Debate, 17% GDP Growth Please, Call of Duty Campaign Review | Katie Drummond, Bing Gordon, Daksh Gupta, Jean-Denis Greze, Quinten Farmer
  14. Chef StationPositiveOct 16, 2026· Biotech Bulls & Breakthroughs

    FDA’s CEDAR approved 46 novel drugs despite an 18% workforce reduction.

    “Cedar approved 46 novel drugs despite an 18% reduction in force across the FDA.”

    Listen at 4:14

    Open the episode · Biotech Stocks to Watch: FDA Shakeups, ESMO Data & Late 2026 Biotech Catalysts Sheff Is Watching
  15. Chef StationPositiveOct 16, 2026· Biotech Bulls & Breakthroughs

    FDA leadership changes could occur in 2027.

    “I think 2027 could be the year that we see this change with the FDA.”

    Listen at 6:44

    Open the episode · Biotech Stocks to Watch: FDA Shakeups, ESMO Data & Late 2026 Biotech Catalysts Sheff Is Watching
  16. Michael PollanPositiveSep 28, 2026· Huberman Lab

    FDA approval for psychedelic medicines will occur soon.

    “I think it will happen soon.”

    Listen at 1:49:31

    Open the episode · What Humans, Animals and Plants Tell Us About Consciousness | Michael Pollan
  17. Kevin RyanNeutralSep 24, 2026· The Tim Ferriss Show

    Advancing one compound through FDA approval costs roughly $200–250 million.

    “it takes, whether we like it or not, it takes roughly $200 to $250 million to get one compound through the FDA process.”

    Listen at 53:38

    Open the episode · #884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many More
  18. Kevin RyanNegativeSep 24, 2026· The Tim Ferriss Show

    Advancing one compound through FDA approval costs roughly $200–250 million

    “it takes, whether we like it or not, it takes roughly $200 to $250 million to get one compound through the FDA process.”

    Listen at 53:38

    Open the episode · #884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many More
  19. Consumers should rely on FDA and CDC guidance during food-safety challenges.

    “I'd listen to the FDA and I'd listen to the CDC.”

    Listen at 17:56

    Open the episode · Mad Money w/ Jim Cramer 7/29/26
  20. Mark KasperPositiveApr 23, 2026· Mad Money w/ Jim Cramer

    The FDA regulatory environment is improving.

    “I'm very confident. that we're moving in the right direction from a regulatory standpoint.”

    Listen at 25:21

    Open the episode · Mad Money w/ Jim Cramer 4/23/26
  21. Robert BarrowPositiveApr 20, 2026· Mad Money w/ Jim Cramer

    The executive order seeks to reduce breakthrough-drug review from six months to one or two.

    “It takes that from even for breakthrough products, it's a six month review cycle and tries to bring that down to one or two months.”

    Listen at 33:00

    Open the episode · Mad Money w/ Jim Cramer 4/20/26
  22. Agilent sees steady drug approvals and favorable FDA conditions for its business.

    “we see a steady release of drugs through it. So from our side, we see that it's going pretty well.”

    Listen at 36:06

    Open the episode · Mad Money w/ Jim Cramer 11/25/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.